Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2010 4
2011 2
2012 4
2013 3
2014 2
2015 1
2016 5
2018 4
2019 1
2020 6
2021 3
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Optimizing cryopreservation conditions for use of fucosylated human mesenchymal stromal cells in anti-inflammatory/immunomodulatory therapeutics.
Gil-Chinchilla JI, Bueno C, Martínez CM, Ferrández-Múrtula A, García-Hernández AM, Blanquer M, Molina-Molina M, Zapata AG, Sackstein R, Moraleda JM, García-Bernal D. Gil-Chinchilla JI, et al. Among authors: blanquer m. Front Immunol. 2024 Mar 28;15:1385691. doi: 10.3389/fimmu.2024.1385691. eCollection 2024. Front Immunol. 2024. PMID: 38605955 Free PMC article.
Heterogeneity of mesenchymal cells in human amniotic membrane at term.
Cortes-Sandoval S, Seco-Rovira V, Beltrán-Frutos E, Serrano-Sánchez MI, Martínez-Hernández J, Ferrer C, Delgado JL, Insausti CL, Blanquer M, Pastor LM. Cortes-Sandoval S, et al. Among authors: blanquer m. Histol Histopathol. 2024 May;39(5):573-593. doi: 10.14670/HH-18-660. Epub 2023 Sep 4. Histol Histopathol. 2024. PMID: 37721417
ZAKα/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome.
Rodríguez-Ruiz L, Lozano-Gil JM, Naranjo-Sánchez E, Martínez-Balsalobre E, Martínez-López A, Lachaud C, Blanquer M, Phung TK, García-Moreno D, Cayuela ML, Tyrkalska SD, Pérez-Oliva AB, Mulero V. Rodríguez-Ruiz L, et al. Among authors: blanquer m. EMBO Mol Med. 2023 Oct 11;15(10):e18142. doi: 10.15252/emmm.202318142. Epub 2023 Sep 7. EMBO Mol Med. 2023. PMID: 37675820 Free PMC article.
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study.
Español I, Leal JD, Blanquer M, García-Candel F, Heredia A, Gómez-Espuch J, González C, Montserrat J, Díaz-Carrasco MS, Martínez A, Moraleda JM. Español I, et al. Among authors: blanquer m. Ann Hematol. 2023 Aug;102(8):2069-2075. doi: 10.1007/s00277-023-05248-9. Epub 2023 May 12. Ann Hematol. 2023. PMID: 37171598 Free PMC article.
Enforced mesenchymal stem cell tissue colonization counteracts immunopathology.
García-Bernal D, Blanquer M, Martínez CM, García-Guillén AI, García-Hernández AM, Carmen Algueró M, Yáñez R, Lamana ML, Moraleda JM, Sackstein R. García-Bernal D, et al. Among authors: blanquer m. NPJ Regen Med. 2022 Oct 19;7(1):61. doi: 10.1038/s41536-022-00258-z. NPJ Regen Med. 2022. PMID: 36261464 Free PMC article.
New Insights Into Pathophysiology of β-Thalassemia.
Sanchez-Villalobos M, Blanquer M, Moraleda JM, Salido EJ, Perez-Oliva AB. Sanchez-Villalobos M, et al. Among authors: blanquer m. Front Med (Lausanne). 2022 Apr 12;9:880752. doi: 10.3389/fmed.2022.880752. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35492364 Free PMC article.
Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.
Minguela A, Vasco-Mogorrón MA, Campillo JA, Cabañas V, Remigia MJ, Berenguer M, García-Garay MC, Blanquer M, Cava C, Galian JA, Gimeno L, Soto-Ramírez MF, Martínez-Hernández MD, de la Rubia J, Teruel AI, Muro M, Periago A. Minguela A, et al. Among authors: blanquer m. Am J Cancer Res. 2021 Sep 15;11(9):4438-4454. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659897 Free PMC article.
Phase 2 Clinical Trial of Infusing Haploidentical K562-mb15-41BBL-Activated and Expanded Natural Killer Cells as Consolidation Therapy for Pediatric Acute Myeloblastic Leukemia.
Gómez García LM, Escudero A, Mestre C, Fuster Soler JL, Martínez AP, Vagace Valero JM, Vela M, Ruz B, Navarro A, Fernández L, Fernández A, Leivas A, Martínez-López J, Ferreras C, De Paz R, Blanquer M, Galán V, González B, Corral D, Sisinni L, Mirones I, Balas A, Vicario JL, Valle P, Borobia AM, Pérez-Martínez A. Gómez García LM, et al. Among authors: blanquer m. Clin Lymphoma Myeloma Leuk. 2021 May;21(5):328-337.e1. doi: 10.1016/j.clml.2021.01.013. Epub 2021 Jan 25. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33610500 Clinical Trial.
41 results